Company: NREF
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001786248-25-000010
Chunk: 7

Company: NexPoint Real Estate Finance, Inc.
Filing Date: 2025-05-12
Form: 10-Q
Item: Item 1
Chunk 7
---
17,711  Cash flows from investing activitiesProceeds from payments received on mortgage loans held in variable interest entities134,424 157,014 Proceeds from payments received on mortgage loans held for investment20,665 511,169 Originations of mortgage loans, held-for-investment, net(18,480)— Originations of loans, held-for-investment, net(4,066)(60,247)Purchases of preferred stock(55,013)(3,507)Purchases of equity method investments— (2,000)Purchases of CMBS securitizations(5,912)— Purchases of CMBS securitizations held in variable interest entities, at fair value18 (26,438)Purchases of mortgage backed securities, at fair value— (44,396)Sale of mortgage backed securities, at fair value— 14,069 Additions to real estate investments(355)(253)Net cash provided by investing activities71,281 545,411 Cash flows from financing activitiesBorrowings under secured financing agreements23,359 — Principal repayments on borrowings under secured financing agreements(6,500)(466,960)Distributions to bondholders of variable interest entities(124,695)(146,100)Borrowings under master repurchase agreements21,760 57,425 Principal repayments on borrowings under master repurchase agreements(6,616)(19,199)Proceeds from the issuance of Series B preferred stock through public offering, net of offering costs39,954 27,491 Principal repayments on mortgages payable(86)(61)Payments for taxes related to net share settlement of stock-based compensation(1,490)(369)Dividends paid to common stockholders(8,771)(8,653)Dividends paid to Series A preferred stockholders(874)(874)Dividends paid to Series B preferred stockholders(4,407)(665)Distributions to redeemable noncontrolling interests in the OP(2,519)(2,519)Net cash used in financing activities(70,885)(560,484)Net increase (decrease) in cash, cash equivalents, and restricted cash16,435 2,638 Cash, cash equivalents and restricted cash, beginning of period7,053 16,649 Cash, cash equivalents and restricted cash, end of period$23,488 $19,287 Supplemental Disclosure of